THRX

Theseus Pharmaceuticals, Inc. Common Stock
THRX

Overview Fund Activity
Delisted

THRX was delisted on the 13th of February, 2024.

Back to rankings

69 hedge funds and large institutions have $374M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-3
Holders Change %
-4.17%
% of All Funds
1.09%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
10
Increased
27
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
Deerfield Management
New York
$13.1M
2
BlackRock
BlackRock
New York
$12.4M
3
PBA
Paradigm Biocapital Advisors
New York
$18.2M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
$2.8M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
$5.93M

Top Sellers

1
FFM
Fairmount Funds Management
Pennsylvania
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$7.52M
3
Bank of America
Bank of America
North Carolina
$37.3K
4
Walleye Capital
Walleye Capital
New York
$0
5
WP
Woodline Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SSA
76
Schonfeld Strategic Advisors
New York
– -$696K -78,369 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– -$161K -18,081 Closed
GCP
78
GSA Capital Partners
United Kingdom
– -$156K -17,543 Closed
JF
79
Jump Financial
Illinois
– -$141K -15,859 Closed
Nisa Investment Advisors
80
Nisa Investment Advisors
Missouri
– -$15K -1,660 Closed
PVH
81
Psagot Value Holdings
Israel
– -$2K -274 Closed
PMEF
82
Point72 Middle East FZE
United Arab Emirates
– -$142 -16 Closed
1 2 3
4